Neoadjuvant systemic therapy for breast cancer: a survey of Australian and New Zealand specialists

被引：0
|
作者：
Zdenkowski, N. [1 ]
Butow, P. [2 ]
Mann, G. B. [3 ]
Fewster, S. [1 ]
Beckmore, C. [1 ]
Isaacs, R. [4 ]
Boyle, F. M. [2 ]
机构：
[1] Australia & New Zealand Breast Canc Trials Grp, Trials Coordinat Dept, Waratah, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] MidCentral Reg Canc Treatment Serv, Palmerston North, New Zealand
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70233-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P199
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [21] Survey of Australian and New Zealand Oral and Maxillofacial Surgery trainees and recent specialists - education and experience
    Szuster, FSP
    Nastri, AL
    Goss, AN
    Spencer, AJ
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2000, 29 (04) : 305 - 308
  • [22] Controversies Concerning the Use of Neoadjuvant Systemic Therapy for Primary Breast Cancer
    Kaufmann, Manfred
    Karn, Thomas
    Ruckhaeberle, Eugen
    WORLD JOURNAL OF SURGERY, 2012, 36 (07) : 1480 - 1485
  • [23] Investigating circulating lncRNAs in breast cancer patients on neoadjuvant systemic therapy
    Krastev, Boris
    Timcheva, Constanta
    Valev, Spartak
    Zhbantov, Georgi
    Petrova, Mila
    Karanikolova, Teodora
    Gencheva, Radostina
    Ivanova, Anika
    Stoykov, Ivaylo
    Stamenov, Georgi
    CANCER RESEARCH, 2020, 80 (04)
  • [24] A survey among breast cancer specialists on the low uptake of breast cancer preventive therapy with tamoxifen or raloxifene
    De Censi, A.
    Noonan, S. F.
    Pasa, A.
    Caviglia, S.
    Bonanni, B.
    Costa, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] Biomarker evolution after neoadjuvant systemic therapy in breast cancer.
    Castillo, Dan Ran
    Pairawan, Seyed Saeed
    Denham, Laura
    Lum, Sharon S.
    Nagaraj, Gayathri
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals
    Mamounas, Eleftherios
    Poulos, Christine
    Goertz, Hans-Peter
    Gonzalez, Juan Marcos
    Pugh, Amy
    Antao, Vincent
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3510 - 3517
  • [27] Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
    Eleftherios Mamounas
    Christine Poulos
    Hans-Peter Goertz
    Juan Marcos González
    Amy Pugh
    Vincent Antao
    Annals of Surgical Oncology, 2016, 23 : 3510 - 3517
  • [28] Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
    A. Eniu
    memo - Magazine of European Medical Oncology, 2008, 1 (3) : 143 - 147
  • [29] Metaplastic Breast Cancer Has a Poor Response to Neoadjuvant Systemic Therapy
    Al-Hilli, Zahraa
    Jakub, James
    Visscher, Daniel
    Ingle, James
    Goetz, Matthew
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 24 - 25
  • [30] Mammographic density to predict response to neoadjuvant systemic breast cancer therapy
    S. Di Cosimo
    C. Depretto
    R. Miceli
    P. Baili
    S. Ljevar
    M. Sant
    V. Cappelletti
    S. Folli
    M. Gennaro
    F. G. De Braud
    G. Bianchi
    A. Vingiani
    G. Pruneri
    A. Marchianò
    E. La Rocca
    M. C. De Santis
    G. P. Scaperrotta
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 775 - 781
12345